Thompson Siegel & Walmsley LLC Amgen Inc Transaction History

Thompson Siegel & Walmsley LLC

$6.43 Billion
Q4 2024

A detailed history of Thompson Siegel & Walmsley LLC transactions in Amgen Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 41,561 shares of AMGN stock, worth $12.3 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

41,561

Previous 41,548 0.03%

Holding current value

$12.3 Million

Previous $13.4 Million 19.09%

% of portfolio

0.17%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$258.78 - $328.31 $3,364 - $4,268	13 Added 0.03%	41,561 $10.8 Million
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $888,229 - $968,617	2,871 Added 7.42%	41,548 $13.4 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $3.36 Million - $4.08 Million	12,784 Added 49.37%	38,677 $12.1 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $3.63 Million - $4.1 Million	14,200 Added 121.44%	25,893 $7.46 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $2.11 Million - $2.63 Million	9,670 Added 478.0%	11,693 $3.14 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $1,354 - $1,651	-6 Reduced 0.3%	2,023 $489,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $464,701 - $590,459	2,029 New	2,029 $532,000
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $15,910 - $18,208	-80 Reduced 3.79%	2,029 $456,000
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $14,858 - $17,409	-70 Reduced 3.21%	2,109 $448,000
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $47,932 - $55,857	216 Added 11.0%	2,179 $542,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $2.3 Million - $2.56 Million	-9,800 Reduced 83.31%	1,963 $499,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $2.02 Million - $2.48 Million	-10,225 Reduced 46.5%	11,763 $2.77 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $355,368 - $471,315	1,950 Added 9.73%	21,988 $4.46 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $382,204 - $491,264	2,020 Added 11.21%	20,038 $4.83 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $46,487 - $55,701	267 Added 1.5%	18,018 $3.49 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $12,502 - $14,655	-75 Reduced 0.42%	17,751 $3.27 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $2.85 Million - $3.32 Million	15,950 Added 850.21%	17,826 $3.47 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $9,820 - $11,071	-53 Reduced 2.75%	1,876 $389,000
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $9,630 - $10,817	-58 Reduced 2.92%	1,929 $356,000
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $276,679 - $323,334	-1,633 Reduced 45.11%	1,987 $339,000
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $8,777 - $9,806	-52 Reduced 1.42%	3,620 $630,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $15,056 - $17,190	90 Added 2.51%	3,672 $685,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,582	3,582 $617,000

Others Institutions Holding AMGN

# of Institutions

3,124

Shares Held

417M

Call Options Held

8.84M

Put Options Held

6.55M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $159B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Account

Thompson Siegel & Walmsley LLC Amgen Inc Transaction History